Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$247,582,179
-$24,600,601 QoQ
Shares Held
10,281,652
+6.1% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#59
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $5,124,714,999 across 15 Drug Manufacturers - General names. PFE ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,697,061 | $2,035,506,044 | |
| 2 | JNJ |
Johnson & Johnson
|
4,126,113 | $1,047,908,917 | |
| 3 | AZN |
Astrazeneca PLC
|
2,746,590 | $520,808,395 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,533,955 | $454,113,217 | |
| 5 | ABBV |
AbbVie Inc.
|
1,279,175 | $321,891,596 | |
| 6 | PFE |
Pfizer Inc
This page
|
10,281,652 | $247,582,179 | |
| 7 | AMGN |
Amgen Inc
|
646,798 | $234,218,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,361,825 | $172,052,970 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $247,582,179 | 10,281,652 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $272,182,780 | 9,693,119 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $183,305,184 | 7,361,654 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $229,646,423 | 9,012,811 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $71,921,243 | 2,967,048 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $48,473,468 | 1,912,923 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $131,214,541 | 4,945,893 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $403,630,288 | 13,947,142 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $386,058,247 | 13,797,650 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $423,253,628 | 15,252,383 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $509,650,627 | 17,702,349 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $565,069,690 | 17,035,565 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $504,113,890 | 13,743,563 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $562,978,106 | 13,798,483 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $632,411,560 | 12,342,146 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $580,856,280 | 13,273,681 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $640,263,991 | 12,211,787 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $517,883,420 | 10,003,543 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $561,195,905 | 9,503,741 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $403,598,871 | 9,383,838 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $335,034,162 | 8,555,520 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $189,775,674 | 5,238,081 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $231,072,970 | 6,277,451 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $248,853,572 | 6,780,758 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $239,023,480 | 7,309,579 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $261,299,198 | 8,005,501 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||